147 related articles for article (PubMed ID: 26136801)
1. A case of oncogenic osteomalacia due to occult nasal sinus tumor.
Ray S; Chakraborty PP; Biswas K; Ghosh S; Mukhopadhyay S; Chowdhury S
Clin Cases Miner Bone Metab; 2015; 12(1):65-8. PubMed ID: 26136801
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic osteomalacia caused by occult nasal mesenchymal tumor: a monster in the cave.
Ray S; Chakraborty PP; Biswas K; Beatrice AM; Ghosh S; Mukhopadhyay S; Chowdhury S
Oxf Med Case Reports; 2015 Apr; 2015(4):265-8. PubMed ID: 26634142
[TBL] [Abstract][Full Text] [Related]
3. Sinonasal hemangiopericytoma caused hypophosphatemic osteomalacia: A case report.
Li J; Huang Y; Yang F; Zhang Q; Chen D; Wang Q
Medicine (Baltimore); 2018 Dec; 97(52):e13849. PubMed ID: 30593185
[TBL] [Abstract][Full Text] [Related]
4. Tumour induced osteomalacia due to a sinonasal hemangiopericytoma: A case report.
Jamal SA; Dickson BC; Radziunas I
World J Clin Cases; 2013 Apr; 1(1):59-63. PubMed ID: 24303466
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic Osteomalacia with Elevated Fibroblast Growth Factor 23: A Rare Case of Paranasal Sinus Tumor Onset.
Rigante M; Loperfido A; Paludetti G
Cureus; 2019 Jun; 11(6):e4919. PubMed ID: 31423395
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic hypophosphatemic osteomalacia associated with a nasal hemangiopericytoma.
Fuentealba C; Pinto D; Ballesteros F; Pacheco D; Boettiger O; Soto N; Fernandez W; Gabler F; Gonzales G; Reginato AJ
J Clin Rheumatol; 2003 Dec; 9(6):373-9. PubMed ID: 17043447
[TBL] [Abstract][Full Text] [Related]
7. Nasal hemangiopericytoma presenting with oncogenic osteomalasia: A case report and literature review.
Gökyer A; Sayın S; Küçükarda A; Çelik M; Güldiken S; Çiçin İ
Curr Probl Cancer; 2021 Jun; 45(3):100704. PubMed ID: 33446319
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic osteomalacia from nasal cavity giant cell tumor.
Battoo AJ; Salih S; Unnikrishnan AG; Jojo A; Bahadur S; Iyer S; Kuriakose MA
Head Neck; 2012 Mar; 34(3):454-7. PubMed ID: 22311466
[TBL] [Abstract][Full Text] [Related]
9. Occult phosphaturic mesenchymal tumour of femur cortex causing oncogenic osteomalacia - diagnostic challenges and clinical outcomes.
Dutta D; Pandey RK; Gogoi R; Solanki N; Madan R; Mondal A; Dogra S; Thapa P
Endokrynol Pol; 2018; 69(2):205-210. PubMed ID: 29442350
[TBL] [Abstract][Full Text] [Related]
10. Sporadic adult-onset hypophosphatemic osteomalacia caused by excessive action of fibroblast growth factor 23.
Hoshino C; Satoh N; Sugawara S; Kuriyama C; Kikuchi A; Ohta M
Intern Med; 2008; 47(5):453-7. PubMed ID: 18310982
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic osteomalacia presenting as bilateral stress fractures of the tibia.
Ohashi K; Ohnishi T; Ishikawa T; Tani H; Uesugi K; Takagi M
Skeletal Radiol; 1999 Jan; 28(1):46-8. PubMed ID: 10068075
[TBL] [Abstract][Full Text] [Related]
12. Sinonasal glomangiopericytoma causing oncogenic osteomalacia.
Lee GG; Dhong HJ; Park YS; Ko YH
Clin Exp Otorhinolaryngol; 2014 Jun; 7(2):145-8. PubMed ID: 24917914
[TBL] [Abstract][Full Text] [Related]
13. Whole-body (99m)Tc-octreotide scintigraphy with SPECT/CT to detect occult tumor inducing paraneoplastic osteomalacia.
Rodrigues NR; Calich AL; Etchebehere M; Ichiki WA; Pereira FP; Amstalden EM; de Sa Etchebehere EC
Clin Nucl Med; 2015 Jan; 40(1):54-7. PubMed ID: 24458181
[TBL] [Abstract][Full Text] [Related]
14. [Oncogenic osteomalacia: the role of the phosphatonins. Diagnostic usefulness of the Fibroblast Growth Factor 23 measurement in one patient].
Dupond JL; Magy N; Mahammedi M; Prie D; Gil H; Meaux-Ruault N; Kantelip B
Rev Med Interne; 2005 Mar; 26(3):238-41. PubMed ID: 15777586
[TBL] [Abstract][Full Text] [Related]
15. Tumor-induced hypophosphatemic osteomalacia associated with tertiary hyperparathyroidism: a case report.
Tartaglia F; Minisola S; Sgueglia M; Blasi S; Brunelli D; Degli Effetti E; Maturo A; Cola A; Custureri F; Campana FP
G Chir; 2006; 27(1-2):9-13. PubMed ID: 16608626
[TBL] [Abstract][Full Text] [Related]
16. Hemangiopericytoma-induced osteomalacia: tumor transplantation in nude mice causes hypophosphatemia and tumor extracts inhibit renal 25-hydroxyvitamin D 1-hydroxylase activity.
Miyauchi A; Fukase M; Tsutsumi M; Fujita T
J Clin Endocrinol Metab; 1988 Jul; 67(1):46-53. PubMed ID: 2837500
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic osteomalacia due to phosphaturic mesenchymal tumor of the craniofacial sinuses.
Guglielmi G; Bisceglia M; Scillitani A; Folpe AL
Clin Cases Miner Bone Metab; 2011 May; 8(2):45-9. PubMed ID: 22461817
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic osteomalacia should be considered in hypophosphatemia, bone pain and pathological fractures.
Kaniuka-Jakubowska S; Biernat W; Lewczuk A; Świątkowska-Stodulska R; Sworczak K
Endokrynol Pol; 2012; 63(3):234-8. PubMed ID: 22744630
[TBL] [Abstract][Full Text] [Related]
19. Intracranial phosphaturic mesenchymal tumors: report of 2 cases.
Mathis DA; Stehel EJ; Beshay JE; Mickey BE; Folpe AL; Raisanen J
J Neurosurg; 2013 Apr; 118(4):903-7. PubMed ID: 23350780
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic osteomalacia: exact tumor localization by co-registration of positron emission and computed tomography.
Hesse E; Moessinger E; Rosenthal H; Laenger F; Brabant G; Petrich T; Gratz KF; Bastian L
J Bone Miner Res; 2007 Jan; 22(1):158-62. PubMed ID: 17014386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
